Figure 2From: IL-2 immunotherapy in chronically SIV-infected Rhesus MacaquesHuman rIL-2 transiently increases CD4+ and CD8+ T cell counts in a dose-dependent manner . Percentages and counts of peripheral blood (A) CD4+, (B) CD8+ T cells and (C) CD20+ B cells were measured at day 0, 7, 15 and 45 after IL-2-treatment (low dose: О,Δ or high dose: ●,▴).Back to article page